110 related articles for article (PubMed ID: 32522538)
1. Guanidinothiosialoside-Human Serum Albumin Conjugate Mimics mucin Barrier to Restrict Influenza Infection.
Yu Y; Zhou JP; Jin YH; Wang X; Shi XX; Yu P; Zhong M; Yang Y
Int J Biol Macromol; 2020 Nov; 162():84-91. PubMed ID: 32522538
[TBL] [Abstract][Full Text] [Related]
2. Preparation of eicosavalent triazolylsialoside-conjugated human serum albumin as a dual hemagglutinin/neuraminidase inhibitor and virion adsorbent for the prevention of influenza infection.
Li Y; Liu HY; Yang MJ; Liu D; Song JQ; Lao Z; Chen Y; Yang Y
Carbohydr Res; 2023 Oct; 532():108918. PubMed ID: 37586142
[TBL] [Abstract][Full Text] [Related]
3. Amide-sialoside protein conjugates as neomucin bioshields prevent influenza virus infection.
Zhong M; Yu Y; Song JQ; Jia TW; Liu AY; Zhao TF; He HJ; Yang MB; Zhang WX; Yang Y
Carbohydr Res; 2020 Sep; 495():108088. PubMed ID: 32807356
[TBL] [Abstract][Full Text] [Related]
4. Synthetic pentatrideca-valent triazolylsialoside inhibits influenza virus hemagglutinin/neuraminidase and aggregates virion particles.
Lao Z; Li Y; Mi X; Tang Q; Li J; Chen Y; Yang Y
Eur J Med Chem; 2023 Nov; 259():115578. PubMed ID: 37467617
[TBL] [Abstract][Full Text] [Related]
5. Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant.
McKimm-Breschkin JL; Barrett S; McKenzie-Kludas C; McAuley J; Streltsov VA; Withers SG
Antiviral Res; 2019 Sep; 169():104542. PubMed ID: 31233807
[TBL] [Abstract][Full Text] [Related]
6. A Zanamivir-protein conjugate mimicking mucin for trapping influenza virion particles and inhibiting neuraminidase activity.
Xue M; Deng A; Wang JN; Mi X; Lao Z; Yang Y
Int J Biol Macromol; 2024 Jun; 275(Pt 1):133564. PubMed ID: 38955298
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of influenza virus infection by multivalent pentacyclic triterpene-functionalized per-O-methylated cyclodextrin conjugates.
Tian Z; Si L; Meng K; Zhou X; Zhang Y; Zhou D; Xiao S
Eur J Med Chem; 2017 Jul; 134():133-139. PubMed ID: 28411453
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of furanocoumarins isolated from Angelica dahurica against influenza a viruses H1N1 and H9N2.
Lee BW; Ha TKQ; Cho HM; An JP; Kim SK; Kim CS; Kim E; Oh WK
J Ethnopharmacol; 2020 Sep; 259():112945. PubMed ID: 32389854
[TBL] [Abstract][Full Text] [Related]
9. Oseltamivir modified bovine serum albumin inhibits neuraminidase activity and accumulates virion particles to disturb influenza virus replication.
Qin HJ; Li S; Zhu YB; Bao YB; Tang Q; Liu WB; Zhong M; Zhao Y; Yang Y
Carbohydr Res; 2022 Oct; 520():108631. PubMed ID: 35839640
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of a Hexavalent Betulinic Acid Derivative as a Hemagglutinin-Targeted Influenza Virus Entry Inhibitor.
Chen Y; Wang X; Zhu Y; Si L; Zhang B; Zhang Y; Zhang L; Zhou D; Xiao S
Mol Pharm; 2020 Jul; 17(7):2546-2554. PubMed ID: 32426985
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.
Wang H; Xu R; Shi Y; Si L; Jiao P; Fan Z; Han X; Wu X; Zhou X; Yu F; Zhang Y; Zhang L; Zhang L; Zhou D; Xiao S
Eur J Med Chem; 2016 Mar; 110():376-88. PubMed ID: 26866456
[TBL] [Abstract][Full Text] [Related]
12. A Novel Natural Influenza A H1N1 Virus Neuraminidase Inhibitory Peptide Derived from Cod Skin Hydrolysates and Its Antiviral Mechanism.
Li J; Chen Y; Yuan N; Zeng M; Zhao Y; Yu R; Liu Z; Wu H; Dong S
Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30308963
[TBL] [Abstract][Full Text] [Related]
13. An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness.
Kwon JJ; Choi WS; Jeong JH; Kim EH; Lee OJ; Yoon SW; Hwang J; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
J Gen Virol; 2018 Mar; 99(3):292-302. PubMed ID: 29493493
[TBL] [Abstract][Full Text] [Related]
14. The seafood Musculus senhousei shows anti-influenza A virus activity by targeting virion envelope lipids.
Chen D; Lu S; Yang G; Pan X; Fan S; Xie X; Chen Q; Li F; Li Z; Wu S; He J
Biochem Pharmacol; 2020 Jul; 177():113982. PubMed ID: 32305436
[TBL] [Abstract][Full Text] [Related]
15. 3D-quantitative structure-activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase.
Lai Y; Yan Y; Liao S; Li Y; Ye Y; Liu N; Zhao F; Xu P
Arch Pharm Res; 2020 May; 43(5):489-502. PubMed ID: 32248350
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.
Ding Y; Dou J; Teng Z; Yu J; Wang T; Lu N; Wang H; Zhou C
Arch Virol; 2014 Dec; 159(12):3269-78. PubMed ID: 25078390
[TBL] [Abstract][Full Text] [Related]
17. Catechin inhibition of influenza neuraminidase and its molecular basis with mass spectrometry.
Müller P; Downard KM
J Pharm Biomed Anal; 2015; 111():222-30. PubMed ID: 25910046
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel derivatives of 7,8-dihydro-6H-imidazo[2,1-b][1,3]benzothiazol-5-one and their virus-inhibiting activity against influenza A virus.
Galochkina AV; Bollikanda RK; Zarubaev VV; Tentler DG; Lavrenteva IN; Slita AV; Chirra N; Kantevari S
Arch Pharm (Weinheim); 2019 Feb; 352(2):e1800225. PubMed ID: 30520524
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of chlorogenic acid against influenza A (H1N1/H3N2) virus and its inhibition of neuraminidase.
Ding Y; Cao Z; Cao L; Ding G; Wang Z; Xiao W
Sci Rep; 2017 Apr; 7():45723. PubMed ID: 28393840
[TBL] [Abstract][Full Text] [Related]
20. Cryptoporic acid E from Cryptoporus volvatus inhibits influenza virus replication in vitro.
Gao L; Han J; Si J; Wang J; Wang H; Sun Y; Bi Y; Liu J; Cao L
Antiviral Res; 2017 Jul; 143():106-112. PubMed ID: 28232246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
